ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -99.8% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -94.6% | 2,000 | -97.1% | 0.00% | -100.0% |
| Q4 2021 | $74,000 | -1.3% | 70,122 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $75,000 | -45.7% | 66,222 | -49.0% | 0.00% | -50.0% |
| Q2 2021 | $138,000 | -6.1% | 129,881 | -13.8% | 0.01% | -14.3% |
| Q1 2021 | $147,000 | +600.0% | 150,743 | +208.6% | 0.01% | – |
| Q4 2020 | $21,000 | +110.0% | 48,850 | -4.4% | 0.00% | -100.0% |
| Q3 2020 | $10,000 | +150.0% | 51,100 | +5577.8% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 900 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
| Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
| Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
| AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
| Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
| Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
| EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
| Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
| EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |